JORDAN CARDIOVASCULAR MEDICAL DEVICES MARKET

INTRODUCTION

A vascular medical device is described as a device utilized in the arteries, veins, or the heart itself to treat, prevent, or manage an illness, injury, or other condition. This vasculature includes the cardiovascular, peripheral vascular, and neurovascular architecture.

Pacemakers, implanted cardioverter defibrillators (ICD), biventricular pacemakers, and cardiac loop recorders are cardiac implantable electronic devices used to manage or monitor irregular heartbeats in persons with specific heart rhythm problems and heart failure.

JORDAN CARDIOVASCULAR MEDICAL DEVICES MARKET SIZE AND FORECAST

The Jordan Cardiovascular Medical Devices market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

NEW PRODUCT LAUNCH

UltraLinQ to launch a new cardiac monitoring product at Arab Health. The firm will exhibit an UltraLinQ Holter Service, made possible by LifeSignals, at the ABHI UK Pavilion. This service combines wireless ECG recording with wearable biosensors of the highest quality for clinical use.

During the standard 24-hour Holter monitoring interval employed in clinical practice, all arrhythmias go unnoticed. By extending the monitoring time to seven days, it is possible to identify all arrhythmias to a level of over 97%, significantly lowering the risk of stroke.

With the help of the UltraLinQ Holter Service, hospitals and specialty clinics may offer additional Holter services to clients physically present at their facilities or remotely at home. The gadget is used to evaluate the patient's heart rhythm as they go about their regular daily activities.

It can record data for up to seven days and allows qualified cardiac technicians to provide Holter reports in less than 36 hours. The method gives hospitals more freedom in how they deliver treatment to a larger patient population using a pay-per-use model without overtaxing medical staff.

The disposable, single-use wearable biosensor gadget enables wire-free, continuous patient monitoring. Exercise, sleep, and showering are all permitted for patients. Additionally, the medical gadget is made to be simple to apply without causing pain or skin irritation.

Access to medical pictures and data is made possible by UltraLinQ, a company that offers cloud-based platforms. Biosensors and cloud-based patient monitoring systems have been developed over the course of more than ten years by LifeSignals, a US-based manufacturer of medical devices.

COMPANY PROFILE

• Johnson & Johnson Services Inc.
• Terumo Corporation
• Edwards Lifesciences Corporation
• Medtronic PLC
• Boston Scientific Corporation
• LivaNova PLC
• GE Group
• Siemens Healthcare

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Jordan Cardiovascular Medical Devices are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Jordan Cardiovascular Medical Devices and key vendor selection criteria
3. Where is the Jordan Cardiovascular Medical Devices manufactured? What is the average margin per unit?
4. Market share of Jordan Cardiovascular Medical Devices market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Jordan Cardiovascular Medical Devices in-house
6. key predictions for next 5 years in Jordan Cardiovascular Medical Devices market
7. Average B-2-B Jordan Cardiovascular Medical Devices market price in all segments
8. Latest trends in Jordan Cardiovascular Medical Devices market, by every market segment
9. The market size (both volume and value) of the Jordan Cardiovascular Medical Devices market in 2023-2030 and every year in between?
10. Production breakup of Jordan Cardiovascular Medical Devices market, by suppliers and their OEM relationship